235
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Effects of vehicles on the percutaneous absorption of donepezil hydrochloride across the excised hairless mouse skin

&
Pages 1125-1130 | Received 29 Nov 2010, Accepted 04 Feb 2011, Published online: 21 Mar 2011
 

Abstract

Objectives: This study aimed to examine the feasibility of developing donepezil transdermal delivery systems (TDSs).

Methods: Solution and pressure-sensitive adhesive (PSA) TDS were formulated using various vehicles and fatty acids, and the in vitro permeation study was conducted using the hairless mouse skin.

Key findings: Permeation fluxes (μg/cm2/h) from solution formulations were generally low (0.05–3.40), except for formulations including isopropyl alcohol (IPA, 51.19), ethyl alcohol (27.32) and water (24.07). Dose-dependent permeation fluxes were obtained (r2 = 0.9754). Even though the addition of fatty acids to IPA failed to increase donepezil permeation rates, it shortened lag times. Compared to those from solution formulations, permeation profiles from PSA TDS were totally different, and penetration rates were considerably low. PSA TDS comprising diethylene glycol monoethyl ether (DGME)-propylene glycol monolaurate (PGML) co-solvents (40:60) showed the highest permeation flux (0.10 ± 0.0024 μg/cm2/h).

Conclusions: IPA-containing solution formulations and DGME-PGML (40: 60)-containing PSA TDS were found to be favorable candidates for donepezil transdermal delivery.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.